Enhancing muscle growth is a key goal in aquaculture. Myostatin (MSTN), a conserved negative regulator of muscle development, is a prime target for genetic improvement. Here, CRISPR/Cas9 was used to disrupt mstnb in the freshwater fish Acrossocheilus fasciatus . High editing efficiency was observed in F 0 juveniles. At 27 months of age, mstnb -mosaic F 0 adults exhibited a pronounced double-muscling phenotype, with increases in body weight (22.07%), body width (18.13%), and body height (13.02%) compared to controls. In the F 1 progeny, mstnb mutant fish showed a 36.1% higher condition factor and a 29.2% larger muscle fiber cross-sectional area compared to controls, suggesting inheritance of the growth trait. Preliminary nutritional analysis indicated potential increases in total amino acid and essential amino acid contents in F 1 muscle, while fatty acid profiles appeared largely stable. Collectively, these findings suggest that mstnb disruption can promote muscle growth and may affect nutritional composition of muscle in A. fasciatus . This study supports mstnb as a promising target for genetic improvement and offers initial insights into the pleiotropic effects of MSTN signaling in fish.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: